von Gamm, M. ; Schaub, A. ; Jones, A. ; Wolf, C. ; Behrens, G.* ; Lichti, J. ; Essig, K.* ; Macht, A. ; Pircher, J.* ; Ehrlich, A.* ; Davari, K.* ; Chauhan, D.* ; Busch, B.* ; Wurst, W. ; Feederle, R. ; Feuchtinger, A. ; Tschöp, M.H. ; Friedel, C.C.* ; Hauck, S.M. ; Sattler, M. ; Geerlof, A. ; Hornung, V.* ; Heissmeyer, V. ; Schulz, C.* ; Heikenwalder, M.* ; Glasmacher, E.
Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3.
J. Exp. Med. 216, 1700-1723 (2019)
The RNase Regnase-1 is a master RNA regulator in macrophages and T cells that degrades cellular and viral RNA upon NF-κB signaling. The roles of its family members, however, remain largely unknown. Here, we analyzed Regnase-3-deficient mice, which develop hypertrophic lymph nodes. We used various mice with immune cell-specific deletions of Regnase-3 to demonstrate that Regnase-3 acts specifically within myeloid cells. Regnase-3 deficiency systemically increased IFN signaling, which increased the proportion of immature B and innate immune cells, and suppressed follicle and germinal center formation. Expression analysis revealed that Regnase-3 and Regnase-1 share protein degradation pathways. Unlike Regnase-1, Regnase-3 expression is high specifically in macrophages and is transcriptionally controlled by IFN signaling. Although direct targets in macrophages remain unknown, Regnase-3 can bind, degrade, and regulate mRNAs, such as Zc3h12a (Regnase-1), in vitro. These data indicate that Regnase-3, like Regnase-1, is an RNase essential for immune homeostasis but has diverged as key regulator in the IFN pathway in macrophages.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Nf-kappa-b; Helper T-cells; Messenger-rna; Gene-expression; Roquin; Family; Inflammation; Macrophages; Microrna; Innate
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0022-1007
e-ISSN
1540-9538
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 216,
Heft: 7,
Seiten: 1700-1723
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Rockefeller University Press
Verlagsort
950 Third Ave, 2nd Flr, New York, Ny 10022 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
30202 - Environmental Health
30204 - Cell Programming and Repair
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Helmholtz Diabetes Center
Enabling and Novel Technologies
Allergy
Genetics and Epidemiology
Immune Response and Infection
PSP-Element(e)
G-501900-226
G-509800-002
G-503000-001
G-503400-002
G-500500-001
G-502210-001
A-630600-001
G-502200-001
G-505700-001
G-501712-001
A-630700-001
G-500390-001
Förderungen
Copyright
Erfassungsdatum
2019-06-04